Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 11:54 am Purchase |
2020-12-31 | 13G | Akouos, Inc. AKUS |
EcoR1 Capital, LLC | 1,975,984 5.700% |
1,975,984 (New Position) |
Filing History |
| 2021-02-16 09:49 am Unchanged |
2020-12-31 | 13G | Savara Inc. SVRA |
EcoR1 Capital, LLC | 3,040,540 5.300% |
0 (Unchanged) |
Filing History |
| 2021-02-12 5:48 pm Sale |
2020-12-31 | 13G | Savara Inc. SVRA |
EcoR1 Capital, LLC | 3,040,540 5.300% |
-1,432,664 (-32.03%) |
Filing History |
| 2021-02-12 5:33 pm Sale |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
EcoR1 Capital, LLC | 20,000 3.600% |
-13,847 (-40.91%) |
Filing History |
| 2021-02-12 5:23 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
EcoR1 Capital, LLC | 93,416 0.200% |
-2,235,076 (-95.99%) |
Filing History |
| 2021-02-12 5:19 pm Sale |
2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
EcoR1 Capital, LLC | 76,628 2.100% |
-153,257 (-66.67%) |
Filing History |
| 2021-02-12 4:15 pm Purchase |
2020-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
EcoR1 Capital, LLC | 365,008 5.400% |
132,744 (+57.15%) |
Filing History |
| 2021-02-12 4:06 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
EcoR1 Capital, LLC | 0 0.000% |
-2,248,306 (Position Closed) |
Filing History |
| 2021-02-12 3:58 pm Sale |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
EcoR1 Capital, LLC | 0 0.000% |
-2,536,156 (Position Closed) |
Filing History |
| 2021-02-12 3:52 pm Sale |
2020-12-31 | 13G | Merus N.V. MRUS |
EcoR1 Capital, LLC | 0 0.000% |
-1,906,861 (Position Closed) |
Filing History |
| 2021-02-12 3:42 pm Sale |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
EcoR1 Capital, LLC | 0 0.000% |
-2,909,800 (Position Closed) |
Filing History |
| 2021-02-12 3:36 pm Sale |
2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA |
EcoR1 Capital, LLC | 0 0.000% |
-3,627,597 (Position Closed) |
Filing History |
| 2021-02-12 3:27 pm Unchanged |
2020-12-31 | 13G | Chiasma, Inc. CHMA |
EcoR1 Capital, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-12 3:18 pm Sale |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
EcoR1 Capital, LLC | 1,509,812 3.500% |
-577,500 (-27.67%) |
Filing History |
| 2021-01-26 12:21 pm Purchase |
2021-01-22 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital, LLC | 4,368,500 6.800% |
4,368,500 (New Position) |
Filing History |
| 2021-01-22 4:27 pm Purchase |
2021-01-12 | 13G | AC Immune SA ACIU |
EcoR1 Capital, LLC | 4,702,160 6.600% |
4,702,160 (New Position) |
Filing History |
| 2021-01-14 4:59 pm Purchase |
2021-01-04 | 13G | AnaptysBio, Inc. ANAB |
EcoR1 Capital, LLC | 3,813,324 13.900% |
1,847,224 (+93.95%) |
Filing History |
| 2021-01-04 4:42 pm Purchase |
2020-12-22 | 13G | ARS Pharmaceuticals, Inc. SPRY |
EcoR1 Capital, LLC | 2,533,635 7.300% |
2,533,635 (New Position) |
Filing History |
| 2021-01-04 4:30 pm Purchase |
2020-12-28 | 13G | GRITSTONE BIO INC GRTSQ |
EcoR1 Capital, LLC | 4,934,932 9.990% |
4,934,932 (New Position) |
Filing History |
| 2020-11-02 4:04 pm Purchase |
2020-10-23 | 13G | Solid Biosciences Inc. SLDB |
EcoR1 Capital, LLC | 351,667 9.800% |
351,667 (New Position) |
Filing History |